GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » FCF Yield %

Addex Therapeutics (XSWX:ADXN) FCF Yield % : -77.62 (As of Dec. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Addex Therapeutics's Trailing 12-Month Free Cash Flow is CHF-5.97 Mil, and Market Cap is CHF7.70 Mil. Therefore, Addex Therapeutics's FCF Yield % for today is -77.62%.

The historical rank and industry rank for Addex Therapeutics's FCF Yield % or its related term are showing as below:

XSWX:ADXN' s FCF Yield % Range Over the Past 10 Years
Min: -339.78   Med: -43.67   Max: -5.43
Current: -77.62

During the past 13 years, the highest FCF Yield % of Addex Therapeutics was -5.43%. The lowest was -339.78%. And the median was -43.67%.

XSWX:ADXN's FCF Yield % is ranked worse than
81.15% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs XSWX:ADXN: -77.62

Addex Therapeutics's FCF Margin % for the quarter that ended in Sep. 2024 was -738.89%.

Addex Therapeutics FCF Yield % Historical Data

The historical data trend for Addex Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics FCF Yield % Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.80 -22.68 -37.39 -211.84 -138.90

Addex Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -139.23 -43.34 -71.57 -145.75 -18.41

Competitive Comparison of Addex Therapeutics's FCF Yield %

For the Biotechnology subindustry, Addex Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Addex Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's FCF Yield % falls into.


Addex Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Addex Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-7.999 / 5.75897
=-138.90%

Addex Therapeutics's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.399 * 4 / 8.6713224
=-18.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Addex Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Addex Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Addex Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » FCF Yield %
Comparable Companies
XAMS:VALUE XAMS:WHA XAMS:MORE XAMS:TFG XAMS:AGIL XAMS:HEIJM XAMS:THEON XAMS:TITAN XAMS:HYDRA XAMS:AZRN VRTX REGN ASX:CSL XKRX:207940 XBRU:UCB ALNY XBRU:ARGX XKRX:068270 BNTX BGNE
Traded in Other Exchanges
ADXN:USA ADXNz:UK
Address
Chemin des Mines 9, Geneva, CHE, 1202
Website
https://www.addextherapeutics.com
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.